DJIA 16,912.11 -70.48 -0.42%
NASDAQ 4,442.70 -2.21 -0.05%
S&P 500 1,969.95 -8.96 -0.45%
market minute promo

6.17 0.56 (9.98%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ARIA $6.17 9.98%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $5.66
Previous Close $5.61
Daily Range $5.60 - $6.28
52-Week Range $2.15 - $23.00
Market Cap $1.2B
P/E Ratio -4.01
Dividend (Yield) $0.00 (0.0%)
Volume 16,622,640
Average Daily Volume 8,548,730
Current FY EPS -$1.02





Ariad Pharmaceuticals, Inc. (ARIA) Description

The Company is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules. Website:

News & Commentary

ARIAD Pharmaceuticals, Inc. Battling Back

Since returning to market, ARIAD Pharmaceuticals has captured about half of the patients on Iclusig before it went off the market, but it'll have a hard time competing with Novartis' and Bristol-Myers Squibb's leukemia drugs.

Storm The Castle: ARIAD Pharmaceuticals (ARIA)

ARIAD Pharmaceuticals (ARIA) Showing Signs Of Perilous Reversal Today

3 Huge Stocks to Trade (or Not)

Ariad Pharmaceuticals (ARIA) Worth Watching: Stock Gains 15.3% - Tale of the Tape

Morning Market Movers

Benzinga's Top #PreMarket Gainers

'Fast Money' Recap: Facebook and Analysts' Expectations

Benzinga's M&A Chatter for Wednesday July 23, 2014

Thursday's ETF Movers: GDXJ, XBI

Yellen, Icahn Comments Put a Lid on Small-Cap Stocks, May Hurt Larger Market

See More ARIA News...

ARIA's Top Competitors

ARIA $6.17 (9.98%)
Current stock: ARIA
AMGN $123.31 (0.54%)
Current stock: AMGN
GILD $92.99 (1.67%)
Current stock: GILD
BIIB $341.73 (1.59%)
Current stock: BIIB